AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2021
Jun 9, 2021
31523_dirs_2021-06-09_db899bb0-d7e6-4c9c-bbf8-e0af688fa7c6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2021-06-07
Reporting Person: Campbell Bradley L (Director, Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-07 | Common Stock | M | 24375 | $2.45 | Acquired | 436397 | Direct |
| 2021-06-07 | Common Stock | M | 15223 | $2.94 | Acquired | 451620 | Direct |
| 2021-06-07 | Common Stock | M | 10653 | $2.52 | Acquired | 462273 | Direct |
| 2021-06-07 | Common Stock | M | 12345 | $3.53 | Acquired | 474618 | Direct |
| 2021-06-07 | Common Stock | F | 17350 | $10.08 | Disposed | 457268 | Direct |
| 2021-06-07 | Common Stock | M | 6623 | $6.45 | Acquired | 463891 | Direct |
| 2021-06-07 | Common Stock | M | 3891 | $4.38 | Acquired | 467782 | Direct |
| 2021-06-07 | Common Stock | S | 10514 | $10.0064 | Disposed | 457268 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-07 | Stock Options (right to buy) | $2.45 | M | 24375 | Disposed | 2024-01-03 | Common Stock (24375) | Direct |
| 2021-06-07 | Stock Options (right to buy) | $2.94 | M | 15223 | Disposed | 2024-06-26 | Common Stock (15223) | Direct |
| 2021-06-07 | Stock Options (right to buy) | $2.52 | M | 10653 | Disposed | 2023-06-18 | Common Stock (10653) | Direct |
| 2021-06-07 | Stock Options (right to buy) | $3.53 | M | 12345 | Disposed | 2023-01-28 | Common Stock (12345) | Direct |
| 2021-06-07 | Stock Options (right to buy) | $6.45 | M | 6623 | Disposed | 2022-02-15 | Common Stock (6623) | Direct |
| 2021-06-07 | Stock Options (right to buy) | $4.38 | M | 3891 | Disposed | 2022-06-04 | Common Stock (3891) | Direct |
Footnotes
F1: Represents shares swapped to cover the strike price of 62,596 options exercised.
F2: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3: This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.00 to $10.065. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: All of the options were fully vested and exercisable as of the transaction date.